✦ LIBER ✦

Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection

✍ Scribed by H. E. KOHRT; D. L. OUYANG; E. B. KEEFFE

Book ID: 108604719
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 499 KB
Volume: 24
Category: Article
ISSN: 0269-2813
DOI: 10.1111/j.1365-2036.2006.03081.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reactivation of hepatitis D virus after

Reactivation of hepatitis D virus after chemotherapy for diffuse large B cell lymphoma despite lamivudine prophylaxis

✍ Ellen Sloth Andersen; Jan Gerstoft; Nina Weis 📂 Article 📅 2010 🏛 Carden Jennings Publishing 🌐 English ⚖ 126 KB

Systematic review: treatment of chronic

Systematic review: treatment of chronic hepatitis B virus infection by pegylated interferon

✍ A. Y. HUI; H. L.-Y. CHAN; A. Y.-K. CHEUNG; G. COOKSLEY; J. J.-Y. SUNG 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

Prognostic indicators of breakthrough he

Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection

✍ Yasuhito Tanaka; Anthony E.T. Yeo; Etsuro Orito; Kiyoaki Ito; Noboru Hirashima; 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 406 KB

Reactivation of chronic hepatitis B viru

Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis

✍ Athina Pyrpasopoulou; Stella Douma; Themistoklis Vassiliadis; Sofia Chatzimichai 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 131 KB

Lamivudine prophylaxis reduces the incid

Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma

✍ Yu-Hong Li; Yi-Fu He; Wen-Qi Jiang; Fen-Hua Wang; Xu-Bin Lin; Li Zhang; Zhong-Ju 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

## Abstract ## BACKGROUND Hepatitis B virus (HBV) infection is a common disease in China. Severe hepatitis is a well recognized complication in HBV carriers with malignant disease who receive cytotoxic chemotherapy. The objective of the current study was to assess the value of antiviral lamivudine

Adefovir dipivoxil therapy in liver tran

Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis

✍ Murat Akyildiz; Zeki Karasu; Murat Zeytunlu; Unal Aydin; Tijen Ozacar; Murat Kil 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB